about
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensusHospitalization for gastrointestinal adverse events attributable to the use of low-dose aspirin among patients 50 years or older also using non-steroidal anti-inflammatory drugs: a retrospective cohort study2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summaryCase-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ.Trends in Operative and Nonoperative Hip Fracture Management 1990-2014: A Longitudinal Analysis of Manitoba Administrative Data.Associations of Body Mass Index With Incident Fractures and Hip Structural Parameters in a Large Canadian Cohort.Hospital mortality after hip fracture surgery in relation to length of stay by care delivery factors: A database study.Osteoporosis-related fracture case definitions for population-based administrative data.Quality indicators for hip fracture patients: a scoping review protocolIndependent external validation of nomograms for predicting risk of low-trauma fracture and hip fracture.Persistent headache after earache.Fracture risk assessment in long-term care: a survey of long-term care physicians.Comparison of fracture risk prediction among individuals with reduced and normal kidney function.Successful knowledge translation intervention in long-term care: final results from the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trial.Determining whether women with osteopenic bone mineral density have low, moderate, or high clinical fracture riskLoss of health related quality of life following low-trauma fractures in the elderlyRecommendations for preventing fracture in long-term care.The burden of illness of osteoporosis in CanadaFeasibility of administrative data for studying complications after hip fracture surgeryAn interdisciplinary knowledge translation intervention in long-term care: study protocol for the vitamin D and osteoporosis study (ViDOS) pilot cluster randomized controlled trialAttempted Suicide Among Students and Young Adults in Montreal, Quebec, Canada: A Retrospective Cross-Sectional Study of Hospitalized and Nonhospitalized Suicide Attempts Based on Chart ReviewAn economic evaluation: Simulation of the cost-effectiveness and cost-utility of universal prevention strategies against osteoporosis-related fractures.Agreement between physicians' and nurses' clinical decisions for the management of the fracture liaison service (4iFLS): the Lucky Bone™ program.The thinker's sign.Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort.Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos).Trends in hip fracture rates in Canada: an age-period-cohort analysis.Effectiveness of antiresorptives for the prevention of nonvertebral low-trauma fractures in a population-based cohort of womenOsteoporosis Canada 2010 guidelines for the assessment of fracture risk.Dietary patterns and incident low-trauma fractures in postmenopausal women and men aged ≥ 50 y: a population-based cohort study.The burden of illness of osteoporosis in Canadian men.Estimating the excess costs for patients with incident fractures, prevalent fractures, and nonfracture osteoporosis.Prevention of osteoporosis-related fractures among postmenopausal women and older men.Bone turnover markers in the management of postmenopausal osteoporosis.Prevalence of vitamin D insufficiency among healthy school-age Cree childrenScoping review of potential quality indicators for hip fracture patient careUse of nonsteroidal antiinflammatory drugs: is there a change in patient risk profile after withdrawal of rofecoxib?Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada.Temporal trends in the incidence of osteoporotic fractures.Osteoporosis epidemiology 2013: implications for diagnosis, risk assessment, and treatment.
P50
Q26996169-C1124456-728C-4584-8D57-C7F6367A9743Q28222091-9417306C-47D6-44EC-A4E9-5F2AD2596BD8Q28295416-A79743CA-16B9-41CD-A864-44294EEC8666Q30240109-79AE7DB6-F5D7-4A53-9EDB-399F0F0BB395Q31143166-86B1A75D-6EF7-4C62-A6F5-EE8CEE2F01A8Q33570559-F9CB9D24-2BB9-4057-8177-B38F5C6AFB98Q33606253-43C712FE-11A7-41C9-903D-BF188DDFA193Q34248274-70B5944F-238C-4B53-B63B-19EB596A60F7Q34397206-2FD4182D-132E-48D4-B5D5-33B9CE7DE081Q34553270-8F70B3C5-DF8E-4B43-A8EA-6663C48E0A05Q34553280-50BDB8AA-06A3-42C7-8CDD-E12DE7C93847Q35020488-0E045DA3-2AB5-401A-904E-A93B00D684EFQ35278384-AA7B9CCF-B627-4534-986A-ED0D14F794B8Q35606206-A3328F07-D4A9-41A4-85DD-6A303AC6514EQ35841869-BAA07B11-BDD6-411E-B661-E7A1C97BE791Q35993966-596D1579-82E1-4A89-869C-53A66D88E80BQ36176941-3F3D0338-129D-4465-A923-1DF9951CBC14Q36353373-2039F887-83F2-453F-AB3A-07F4F894487DQ36363718-F3E6576F-94E1-483D-9A1E-1E50BC4E6020Q36498838-C69DE766-6FF4-4930-B3E7-D4B8477B08C2Q36518665-4651E92A-CF79-4B8D-947C-FE18169E58E4Q36631752-8E874AF5-ABD6-4F2C-AEB9-8E986D58027BQ36686195-CE5CEF71-D830-47E8-B632-DA91EA4F68D2Q36856789-41A60FD2-E0ED-497C-B98E-C719A7F1452BQ37393267-1E5FCBB4-F11D-4E2E-84DB-20F658184035Q37395875-D07F15FB-B030-4E8D-9E64-B800AF09BFA9Q37395882-83568295-D4E4-4D55-86FF-96940AA828BFQ37401847-96E0DE8A-8F3D-4D6B-8F9F-F14F64C3508DQ37401890-E4C24924-2769-4340-80E8-22DBEBEADF87Q37401905-EB4FDF88-1B42-460D-B2D7-4265CB54D227Q37407691-C37D4C7F-8482-47AD-88C6-7DB2803C974CQ37415660-E5E1EC8F-0FD9-46D5-8C1D-7710FA840FD1Q37428448-FCE988AE-F701-4754-8E25-7D276422617FQ37442018-F27962B7-7AC1-4317-959E-1483B61D298BQ37649383-0237F392-58BE-4DE4-9748-9CC41E5DE6A5Q37728242-D249C6BC-8F40-47B2-BDC4-7A823CBCAD39Q37809642-D56056A4-9849-4902-B3D9-873E70FCE876Q38112571-F103A6C5-F314-4AB2-BD64-DD081E421813Q38147022-09F784DC-309D-4B6B-817A-9698BF8E5708Q38210139-51109A73-B850-44D6-BCB5-ABCF31B08EF1
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Suzanne N Morin
@ast
Suzanne N Morin
@en
Suzanne N Morin
@es
Suzanne N Morin
@nl
type
label
Suzanne N Morin
@ast
Suzanne N Morin
@en
Suzanne N Morin
@es
Suzanne N Morin
@nl
prefLabel
Suzanne N Morin
@ast
Suzanne N Morin
@en
Suzanne N Morin
@es
Suzanne N Morin
@nl
P106
P1153
24780896100
P21
P31
P496
0000-0002-4317-492X